ABCL 4.16 ▲ 4.26% Live Trading Data - Stocknear

AbCellera Biologics Inc.

NASDAQ: ABCL · Real-Time Price · USD
4.16
0.17 (4.26%)
At close: Sep 04, 2025, 3:59 PM
4.23
1.65%
Pre-market: Sep 05, 2025, 09:17 AM EDT
4.26%
Bid 4.08
Market Cap 1.24B
Revenue (ttm) 32.88M
Net Income (ttm) -165.66M
EPS (ttm) -0.56
PE Ratio (ttm) -7.43
Forward PE -8.67
Analyst Buy
Ask 4.19
Volume 6,670,445
Avg. Volume (20D) 6,494,353
Open 3.98
Previous Close 3.99
Day's Range 3.83 - 4.17
52-Week Range 1.89 - 5.82
Beta 0.65

About ABCL

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ABCL
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ABCL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

AbCellera Biologics Inc. is scheduled to release its earnings on Nov 3, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+0.24%
ABCL stock has given up its prior gain. AbCellera ... Unlock content with Pro Subscription
4 weeks ago
+0.24%
AbCellera Biologics shares are trading higher after the company reported better-than-expected Q2 financial results and announced the dosing initiation of its Phase 1 ABCL635 trial.